Literature DB >> 23731902

Diabetes mellitus and decompensated cirrhosis: risk of hepatic encephalopathy in different age groups.

Zeeshan Butt1, Nauman A Jadoon, Osman N Salaria, Kamran Mushtaq, Irbaz B Riaz, Ahmed Shahzad, Ali M Hashmi, Shahid Sarwar.   

Abstract

BACKGROUND: The aim of the present study was to examine the association of diabetes mellitus (DM) with the prevalence and severity of hepatic encephalopathy (HE) in patients with decompensated cirrhosis (DC) and determine the impact of age and gender on this relationship.
METHODS: West Haven criteria was used to prospectively evaluate 352 consecutive patients with DC for the presence of HE. Detailed clinicobiochemical profiling of patients was performed. Categorical data and ordered categorical variables were evaluated using the Chi-squared test for independence and trend, respectively. Continuous normal and non-parametric data were evaluated using the t-test and Mann-Whitney U-test, respectively.
RESULTS: At the time of admission, HE was present in 50.3% of patients. In all, 118 patients had DM (33.5%). Patients with DM had a significantly higher prevalence (58.5% vs 42.6%; P = 0.03) and severity of HE (P(trend) = 0.01) than patients without DM. However, there were no significant differences between the two groups in terms of Child-Pugh class, MELD scores, the presence of ascites and esophageal varices. Patients with DM had higher platelet counts than those without DM (P(trend) = 0.003). In age and gender subgroup analyses, older patients and men with DM had significantly greater evidence of HE (P = 0.02 and 0.03, respectively). Multivariate analysis showed that DM (P = 0.03) and older age (P = 0.006) were independently related to HE, whereas the association of gender was non-significant.
CONCLUSION: Both DM and older age are independently associated with HE in patients with cirrhosis.
© 2013 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  diabetes complications; hepatic encephalopathy; liver cirrhosis; old age; 糖尿病并发症,肝性脑病,肝硬化,老龄

Mesh:

Year:  2013        PMID: 23731902     DOI: 10.1111/1753-0407.12067

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  10 in total

1.  Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes.

Authors:  Xiaodan Zhang; William S Harmsen; Teresa A Mettler; W Ray Kim; Rosebud O Roberts; Terry M Therneau; Lewis R Roberts; Roongruedee Chaiteerakij
Journal:  Hepatology       Date:  2014-07-31       Impact factor: 17.425

2.  Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.

Authors:  Tsai-Ling Liu; Justin Trogdon; Morris Weinberger; Bruce Fried; A Sidney Barritt
Journal:  Dig Dis Sci       Date:  2016-08-01       Impact factor: 3.199

Review 3.  Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy.

Authors:  Diego García-Compeán; José Alberto González-González; Fernando Javier Lavalle-González; Emmanuel Irineo González-Moreno; Jesús Zacarías Villarreal-Pérez; Héctor J Maldonado-Garza
Journal:  Dig Dis Sci       Date:  2016-02       Impact factor: 3.199

Review 4.  Diabetes mellitus - risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis?

Authors:  Simon Johannes Gairing; Eva Maria Schleicher; Christian Labenz
Journal:  Metab Brain Dis       Date:  2022-08-24       Impact factor: 3.655

5.  Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases.

Authors:  Evan J Raff; Donny Kakati; Joseph R Bloomer; Mohamed Shoreibah; Khalid Rasheed; Ashwani K Singal
Journal:  J Clin Transl Hepatol       Date:  2015-03-15

6.  Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis C patients in China.

Authors:  Xu Li; Hongqin Xu; Yang Gao; Meng Pan; Le Wang; Pujun Gao
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

7.  Development and Validation of Prognostic Models to Estimate the Risk of Overt Hepatic Encephalopathy After TIPS Creation: A Multicenter Study.

Authors:  Chongtu Yang; Xiaoli Zhu; Jiacheng Liu; Qin Shi; Hang Du; Yang Chen; Songjiang Huang; Chen Zhou; Yingliang Wang; Tongqiang Li; Yaowei Bai; Bin Xiong
Journal:  Clin Transl Gastroenterol       Date:  2022-01-27       Impact factor: 4.396

8.  Glucagon-Like Peptide-1 Receptor Agonists and Hepatic Decompensation Events in Patients With Cirrhosis and Diabetes.

Authors:  Tracey G Simon; Elisabetta Patorno; Sebastian Schneeweiss
Journal:  Clin Gastroenterol Hepatol       Date:  2021-07-10       Impact factor: 13.576

9.  Association Between Type 2 Diabetes Mellitus, HbA1c and the Risk for Spontaneous Bacterial Peritonitis in Patients with Decompensated Liver Cirrhosis and Ascites.

Authors:  Tammo L Tergast; Hans Laser; Svetlana Gerbel; Michael P Manns; Markus Cornberg; Benjamin Maasoumy
Journal:  Clin Transl Gastroenterol       Date:  2018-09-24       Impact factor: 4.488

10.  Type 2 Diabetes: A Risk Factor for Hospital Readmissions and Mortality in Australian Patients With Cirrhosis.

Authors:  Sang Bong Ahn; Elizabeth E Powell; Anthony Russell; Gunter Hartel; Katharine M Irvine; Chris Moser; Patricia C Valery
Journal:  Hepatol Commun       Date:  2020-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.